
Notice to Pension Funds, Asset Managers, and Fiduciaries Holding PODD: Institutional Portfolios Face Significant Exposure Following Two Omnipod Medical Device Corrections and Over $90 Per Share Decline from Pre-Disclosure Levels NEW YORK, July 9, 2026 /PRNewswire/ -- Institutional investors holding positions in Insulet Corporation (NASDAQ: PODD) during the period from February 21, 2025 through May 26, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment.










